Differences in Family Health History Knowledge Among Bisexual and Lesbian Women

LGBT Health
Megan C RobertsMichelle I Silver

Abstract

We aimed to determine whether there are differences between sexual minority women and heterosexual women in family health history knowledge. We used data from Dr. Susan Love Research Foundation's The Health of Women Study®. We included women who completed two of six online surveys between 2012 and 2015 (n = 22,410). Compared with heterosexual women, bisexual and lesbian women had consistently greater odds of not knowing their family health history (e.g., odds ratios of 2.59 and 1.56 for breast cancer, respectively). To avoid exacerbating existing health disparities, in the era of precision medicine, we must address gaps in knowledge of family health history.

References

Jan 1, 1989·Journal of Homosexuality·E F Strommen
May 4, 2004·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Suzanne L DibbleBrenda Nussey
Jan 25, 2005·Journal of Women's Health·Patricia CaseDonna Spiegelman
Jan 19, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Pamela SankarCynthia Schairer
Apr 29, 2009·Journal of Transcultural Nursing : Official Journal of the Transcultural Nursing Society·Barbara Burns McGrath, Karen L Edwards
May 13, 2011·Journal of the National Cancer Institute·Phuong L MaiLouise Wideroff
May 10, 2012·Journal of Community Genetics·Sato AshidaKimberly A Kaphingst

❮ Previous
Next ❯

Citations

Nov 20, 2020·Preventing Chronic Disease·Melinda KrakowRobin C Vanderpool

❮ Previous
Next ❯

Software Mentioned

Stata SE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Preventive Medicine
Keren LehavotTracy L Simpson
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
S Bryn AustinDonna Spiegelman
Journal of Consulting and Clinical Psychology
Ulrike BoehmerMichael Winter
Journal of Women's Health
John R BlosnichJillian C Shipherd
© 2022 Meta ULC. All rights reserved